NCT02430142

Brief Summary

Forearm vasoocclusive testing (VOT) will be performed with laser-doppler spectrophotometry system in septic patients on ICU. Microcirculatory oxygen uptake will be checked for prognostic value and for associations with tissue hypoxia markers and high central venus saturations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

April 16, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 30, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

May 2, 2018

Status Verified

May 1, 2018

Enrollment Period

1.5 years

First QC Date

April 16, 2015

Last Update Submit

May 1, 2018

Conditions

Keywords

microcirculationoxygen uptakehypoxiaadenosinecentral venous saturationhypoxanthinelaserdoppler

Outcome Measures

Primary Outcomes (1)

  • Overall Survival

    ICU-Mortality, 60-days-mortlity, 180-days-mortality will be recorded and correlated with baseline and postischemic microcirculatory oxygen delivery and uptake.

    180 days

Secondary Outcomes (3)

  • Connection between ScvO2 and microcirculatory oxygen uptake

    Day 1 and day 4

  • Connection between adenosine-metabolites and microcirculatory oxygen uptake

    Day 1 and day 4

  • Physical condition

    180 days

Study Arms (3)

Vasoocclusive testing in sepsis

Septic patients defined according to the Surviving Sepsis Campaign (SSC)

Other: Vasoocclusive testing

Vasoocclusive testing in severe sepsis

Severe septic patients defined according to the Surviving Sepsis Campaign (SSC)

Other: Vasoocclusive testing

Vasoocclusive testing in sepsic shock

Septic shock patients defined according to the Surviving Sepsis Campaign (SSC)

Other: Vasoocclusive testing

Interventions

Forearm vasoocclusive testing with a laser-doppler spectrophotometry system, transpulmonary thermodilution and blood sampling;

Vasoocclusive testing in sepsic shockVasoocclusive testing in sepsisVasoocclusive testing in severe sepsis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients admitted a surgical intensive care unit within the last 24 hours and the diagnosis of sepsis, severe sepsis and septic shock according to the Surviving Sepsis Campaign.

You may qualify if:

  • Criteria according to the SSC for sepsis, severe sepsis and septic shock
  • Admission to the ICU within 24 hours

You may not qualify if:

  • Pregnancy
  • Cardiopulmonary resuscitation within the last 5 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Centre, Department of Anaesthesiology and Surgical Intensive Care Medicine

Mannheim, 68167, Germany

Location

Related Publications (7)

  • Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013 Aug 29;369(9):840-51. doi: 10.1056/NEJMra1208623. No abstract available.

    PMID: 23984731BACKGROUND
  • De Backer D, Donadello K, Cortes DO. Monitoring the microcirculation. J Clin Monit Comput. 2012 Oct;26(5):361-6. doi: 10.1007/s10877-012-9383-8. Epub 2012 Jul 26.

    PMID: 22833180BACKGROUND
  • Shapiro NI, Arnold R, Sherwin R, O'Connor J, Najarro G, Singh S, Lundy D, Nelson T, Trzeciak SW, Jones AE; Emergency Medicine Shock Research Network (EMShockNet). The association of near-infrared spectroscopy-derived tissue oxygenation measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Crit Care. 2011;15(5):R223. doi: 10.1186/cc10463. Epub 2011 Sep 22.

    PMID: 21939529BACKGROUND
  • Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004 Sep;32(9):1825-31. doi: 10.1097/01.ccm.0000138558.16257.3f.

    PMID: 15343008BACKGROUND
  • Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.

    PMID: 23353941BACKGROUND
  • Textoris J, Fouche L, Wiramus S, Antonini F, Tho S, Martin C, Leone M. High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality. Crit Care. 2011 Jul 26;15(4):R176. doi: 10.1186/cc10325.

    PMID: 21791065BACKGROUND
  • van der Voort PH, van Zanten M, Bosman RJ, van Stijn I, Wester JP, van Raalte R, Oudemans-van Straaten HM, Zandstra DF. Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: a randomised controlled pilot study. Eur J Anaesthesiol. 2015 Mar;32(3):189-98. doi: 10.1097/EJA.0000000000000126.

    PMID: 25032942BACKGROUND

MeSH Terms

Conditions

SepsisShock, SepticHypoxia

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShockSigns and Symptoms, RespiratorySigns and Symptoms

Study Officials

  • Manfred Thiel, Prof. Dr. med.

    Department of Anaesthesiology and Surgical Intensive Care, University Medical Centre of Mannheim

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med. Timo Sturm, DESA

Study Record Dates

First Submitted

April 16, 2015

First Posted

April 30, 2015

Study Start

April 1, 2015

Primary Completion

October 1, 2016

Study Completion

August 1, 2017

Last Updated

May 2, 2018

Record last verified: 2018-05

Locations